Sanofi Jumps As Dupixent Nears $5 Billion In Sales; Trump Drug Talks Continue

Published 2 weeks ago Positive
Sanofi Jumps As Dupixent Nears $5 Billion In Sales; Trump Drug Talks Continue
Auto
Sanofi stock jumped early Friday on better-than-expected third-quarter sales and earnings, and a strong showing from Dupixent.

Continue Reading

View Comments

More News

Apache Creek Golf Club Completes Strategic Course and Facility Enhancements to Elevate Guest Experience and Asset Value

11 minutes ago Positive

Tether to emerge as largest shareholder of VCI Global following OOB token deal

12 minutes ago Positive

Big Insider Purchases by Carl Icahn, Mario Gabelli, and Others

17 minutes ago Positive

China Nitrites and Nitrates Industry Business Report 2025: PESTEL Analysis, Producers, Foreign Trade, Major Wholesalers and Trading Companies, Downstream Markets

19 minutes ago Positive

China Metal and Nonmetallic Chlorides, Bromides and Iodides, Chloride Oxides and Bromides Oxides Industry Business Report 2025

20 minutes ago Positive